BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 28693017)

  • 1. The Bethesda System for Reporting Cervical Cytology: A Historical Perspective.
    Nayar R; Wilbur DC
    Acta Cytol; 2017; 61(4-5):359-372. PubMed ID: 28693017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A Groundbreaking Work Which Laid the Foundation for Mass Screening in Cervical Cytology in Japan.
    Osamura RY
    Acta Cytol; 2017; 61(4-5):299-304. PubMed ID: 28693014
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Criticism of the Pap Smear as a Diagnostic Tool in Cervical Cancer Screening.
    Schneider V
    Acta Cytol; 2017; 61(4-5):338-344. PubMed ID: 28693015
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glandular Lesions of the Cervix in Clinical Practice: A Cytology, Histology, and Human Papillomavirus Correlation Study From 2 Institutions.
    Miller RA; Mody DR; Tams KC; Thrall MJ
    Arch Pathol Lab Med; 2015 Nov; 139(11):1431-6. PubMed ID: 25951104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Prevalence of Abnormal Cervical Cytology in HIVNegative Women Participating in a Cervical Cancer Screening Program in Calmette Hospital, Cambodia.
    Hav M; Eav S; Heang N; Pich P; Lim D; Leang V; Korn A; Lay S; Pluot M; Kruy L
    Asian Pac J Cancer Prev; 2016; 17(7):3101-3. PubMed ID: 27509936
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Study points to value of HPV screening for cervical cancer: test may be viable alternative to Pap test.
    Printz C
    Cancer; 2014 Dec; 120(23):3589-90. PubMed ID: 25410486
    [No Abstract]   [Full Text] [Related]  

  • 7. History of high-risk HPV and Pap test results in a large cohort of patients with invasive cervical carcinoma: experience from the largest women's hospital in China.
    Tao X; Griffith CC; Zhou X; Wang Z; Yan Y; Li Z; Zhao C
    Cancer Cytopathol; 2015 Jul; 123(7):421-7. PubMed ID: 25955972
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Current status and future trends in cervical cancer screening.
    Castle P; Dowdall M
    Womens Health (Lond); 2014 Mar; 10(2):129-33. PubMed ID: 24147567
    [No Abstract]   [Full Text] [Related]  

  • 9. Implementation of a real-time reference and calibration grid platform for improved screening - mapping in Pap test slides.
    Tsiambas E; Riziotis C
    Pathol Int; 2017 Jan; 67(1):24-31. PubMed ID: 27891686
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cervical cancer screening in Korea: report on the National Cancer Screening Programme in 2008.
    Mun JY; Han MA; Lee HY; Jun JK; Choi KS; Park EC
    Asian Pac J Cancer Prev; 2011; 12(8):1961-4. PubMed ID: 22292633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pap Test Reporting Rates for Conventional Smear and Liquid-Based Cervical Cytology from the Largest Academic Women's Hospital in China: Analysis of 1,248,785 Pap Test Reports.
    Tao X; Austin RM; Zhang H; Zhang L; Xiao J; Wang L; Zhou X; Zhao C
    Acta Cytol; 2015; 59(6):445-51. PubMed ID: 26789332
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Liquid-based cervical cytology ThinPrep screening in Hungary].
    Bak M; Séberné Éll M; Bóka M; Veleczki Z; Nyári T; Pete I; Szentirmay Z
    Orv Hetil; 2014 May; 155(18):708-14. PubMed ID: 24776385
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Abnormal cervical cytology: new names, familiar smears.
    Carulli DT
    J Am Acad Nurse Pract; 2003 Oct; 15(10):444-9. PubMed ID: 14606133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The ecologization of the Papanicolaou stain in the diagnosis of cervical cancer].
    Rojas-Zumaran V; Moya-Salazar J
    Rev Med Inst Mex Seguro Soc; 2018 Oct; 56(3):217-225. PubMed ID: 30365481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Bethesda system for the reporting of cervical/vaginal cytology.
    Oren A; Fernandes J
    J Am Osteopath Assoc; 1991 May; 91(5):476-9. PubMed ID: 2061103
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Liquid-based cytology: is this the way forward for cervical screening?
    Moseley RP; Paget S
    Cytopathology; 2002 Apr; 13(2):71-82. PubMed ID: 11952745
    [TBL] [Abstract][Full Text] [Related]  

  • 17. False-Negative Rate of Papanicolaou Testing: A National Survey from the Thai Society of Cytology.
    Koonmee S; Bychkov A; Shuangshoti S; Bhummichitra K; Himakhun W; Karalak A; Rangdaeng S
    Acta Cytol; 2017; 61(6):434-440. PubMed ID: 28738387
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bethesda 2014: improving on a paradigm shift.
    Wilbur DC; Nayar R
    Cytopathology; 2015 Dec; 26(6):339-42. PubMed ID: 26767599
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Pap Test and Bethesda 2014: "The reports of my demise have been greatly exaggerated. (after a quotation from Mark Twain)".
    Nayar R; Wilbur DC
    J Low Genit Tract Dis; 2015 Jul; 19(3):175-84. PubMed ID: 25943863
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Bethesda System, the pathology of preinvasive lesions, and screening technology. The Bethesda System (TBS) of nomenclature for cervical smears.
    Henry M
    J Natl Cancer Inst Monogr; 1996; (21):13-6. PubMed ID: 9101702
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 12.